Suppression of panel-reactive antibodies by treatment with mycophenolate mofetil

Thoracic and Cardiovascular Surgeon

Volumn 46, Issue 3, 1998, Pages 161-162

  Schmid, C ^a   Garritsen, H S P ^a   Kelsch, R ^a   Cassens, U ^a   Baba, H A ^b   Sibrowski, W ^a   Scheld, H H ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Antibody; Mechanical assistance; Transplantation

Indexed keywords

ANTICOAGULANT AGENT; CATECHOLAMINE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; ANTIBODY TITER; ARTICLE; ASSISTED CIRCULATION; CASE REPORT; DEEP VEIN THROMBOSIS; FEMALE; GRAFT REJECTION; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMPLANTATION; INTRAVENOUS DRUG ADMINISTRATION; MYOCARDITIS; ORAL DRUG ADMINISTRATION; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL;

EID: 0031812627     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1010217     Document Type: Article

References (8)

1. Rose ML. Antibody-mediated rejection following cardiac transplantation. Transplant Rev. 1993;7:140-52.
2. Lavee J, Kormos RL, Duquesnoy RJ, et al. Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation. J Heart Lung Transplant. 1991;10:921-30.
3. Loh E, Bergin JD, Couper GS, Mudge GH Jr. Role of panel-reactive antibody crossreactivity in predicting survival after orthotopic heart transplantation. J Heart Lung Transplant. 1994;13:194-201.
4. Cooper LT, Berry GJ, Shabetai R, for the Multicenter Giant Cell Myocarditis Study Group Investigators. Idiopathic giant-cell myocarditis - natural history and treatment. N Engl J Med. 1997;336:1860-6.
5. Hammond EH, Yowell RL, Nunoda S, et al. Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Transplant. 1989;8:430-43.
6. Kemnitz J, Cremer J, Restropo-Specht I, et al. Hyperacute rejection in heart allografts. Pathol Res Prac. 1991;187:23-9.
7. Rose ML. Cellular and humoral rejection after cardiac transplantation. Cardiovasc Eng. 1997;2:19-33.
8. Weyand M, Frye K, Fahrenkamp A, et al. Cyclophosphamide as an adjunct to maintenance immunosuppression in cardiac transplantation. Transplant Proc. 1995;27:1967-8.